N-(4-(2-(6,7-Dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)ethyl)phenyl)-4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)-amino)benzamide

ID: ALA4875177

PubChem CID: 164625717

Max Phase: Preclinical

Molecular Formula: C36H36N6O3

Molecular Weight: 600.72

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  COc1cc2c(cc1OC)CN(CCc1ccc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc1)CC2

Standard InChI:  InChI=1S/C36H36N6O3/c1-24-6-9-27(19-32(24)41-36-38-16-12-31(40-36)28-5-4-15-37-22-28)35(43)39-30-10-7-25(8-11-30)13-17-42-18-14-26-20-33(44-2)34(45-3)21-29(26)23-42/h4-12,15-16,19-22H,13-14,17-18,23H2,1-3H3,(H,39,43)(H,38,40,41)

Standard InChI Key:  BJGZEIOOQZNXAL-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 45 50  0  0  0  0  0  0  0  0999 V2000
   22.3021  -31.8911    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.3010  -32.7147    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.0132  -33.1237    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.7269  -32.7142    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.7241  -31.8875    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.0114  -31.4781    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.0089  -30.6568    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.7195  -30.2460    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.4264  -30.6549    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.1365  -30.2449    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.1345  -29.4227    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.4165  -29.0123    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.7134  -29.4287    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.9986  -29.0211    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.8493  -30.6517    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.8514  -31.4730    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   26.5602  -30.2413    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   27.2730  -30.6482    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.2720  -31.4671    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.9840  -31.8779    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.6958  -31.4634    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.6911  -30.6379    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.9786  -30.2348    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.4092  -31.8734    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.1154  -31.4580    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.8288  -31.8680    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   30.8272  -32.6884    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.5365  -33.0943    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.5342  -31.4497    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.2480  -31.8642    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.2476  -32.6858    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.9584  -33.0932    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.6701  -32.6841    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.6666  -31.8593    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.9552  -31.4516    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.3765  -31.4434    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   34.3830  -33.0910    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   35.0897  -32.6807    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.0861  -31.8528    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.4318  -33.1210    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.4307  -33.9393    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.1377  -34.3476    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.8463  -33.9387    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.8434  -33.1173    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   25.1358  -32.7127    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13  8  1  0
 13 14  1  0
 10 15  1  0
 15 16  2  0
 15 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 18  1  0
 21 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 26 29  1  0
 27 28  1  0
 28 31  1  0
 30 29  1  0
 30 31  2  0
 31 32  1  0
 32 33  2  0
 33 34  1  0
 34 35  2  0
 35 30  1  0
 34 36  1  0
 33 37  1  0
 37 38  1  0
 36 39  1  0
 40 41  2  0
 41 42  1  0
 42 43  2  0
 43 44  1  0
 44 45  2  0
 45 40  1  0
  4 40  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4875177

    ---

Associated Targets(Human)

K562 (73714 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
K562/A02 (383 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ABCB1 Tchem P-glycoprotein 1 (14716 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

MDCK-II (565 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 600.72Molecular Weight (Monoisotopic): 600.2849AlogP: 6.46#Rotatable Bonds: 10
Polar Surface Area: 101.50Molecular Species: NEUTRALHBA: 8HBD: 2
#RO5 Violations: 2HBA (Lipinski): 9HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: 12.38CX Basic pKa: 8.36CX LogP: 6.27CX LogD: 5.27
Aromatic Rings: 5Heavy Atoms: 45QED Weighted: 0.19Np Likeness Score: -1.36

References

1. Qiu Q, Zou F, Li H, Shi W, Zhou D, Zhang P, Li T, Yin Z, Cai Z, Jiang Y, Huang W, Qian H..  (2021)  Structure-Based Discovery of Pyrimidine Aminobenzene Derivatives as Potent Oral Reversal Agents against P-gp- and BCRP-Mediated Multidrug Resistance.,  64  (9.0): [PMID:33938746] [10.1021/acs.jmedchem.1c00246]

Source